staurosporine aglycone has been researched along with Obesity in 1 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamada, N | 1 |
| Katsuura, G | 1 |
| Ochi, Y | 1 |
| Ebihara, K | 1 |
| Kusakabe, T | 1 |
| Hosoda, K | 1 |
| Nakao, K | 1 |
1 other study available for staurosporine aglycone and Obesity
| Article | Year |
|---|---|
Impaired CNS leptin action is implicated in depression associated with obesity.
Topics: Animals; Behavior, Animal; Brain Mapping; Brain-Derived Neurotrophic Factor; Carbazoles; Depression; | 2011 |